Clonal integration site expansion of infected cells is a main contributor of HIV persistence in more differentiated T cell subsets during suppressive ART

• J. Symons,
• C. Bacchus-Souffan,
• A. Chopra,
• S. Leary,
• D. Cameron,
• P.U. Cameron,
• R. Hoh,
• H. Ahn,
• S.G. Deeks,
• J.M. McCune,
• S. Mallal,
• P.W. Hunt,
• S.R. Lewin

Affiliations

J. Symons

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

C. Bacchus-Souffan

University of California - San Francisco, Division of Experimental Medicine, Department of Medicine, San Francisco, USA

A. Chopra

Murdoch University, Institute for Immunology and Infectious Diseases, Murdoch, Australia

S. Leary

Murdoch University, Institute for Immunology and Infectious Diseases, Murdoch, Australia

D. Cameron

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

P.U. Cameron

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia; Alfred Hospital and Monash University, Department of Infectious Diseases, Melbourne, Australia

R. Hoh

University of California - San Francisco, Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, San Francisco, USA

H. Ahn

University of California - San Francisco, Division of Experimental Medicine, Department of Medicine, San Francisco, USA

S.G. Deeks

University of California - San Francisco, Division of HIV, Infectious diseases and Global Medicine, Department of Medicine, San Francisco, USA

J.M. McCune

University of California - San Francisco, Division of Experimental Medicine, Department of Medicine, San Francisco, USA

S. Mallal

Murdoch University, Institute for Immunology and Infectious Diseases, Murdoch, Australia; Vanderbilt University Medical Center (VUMC), Department of Medicine, Nashville, USA

P.W. Hunt

University of California - San Francisco, Division of Experimental Medicine, Department of Medicine, San Francisco, USA

S.R. Lewin

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia; Alfred Hospital and Monash University, Department of Infectious Diseases, Melbourne, Australia